• Effectiveness Of Identifying A Cancer Patient In The Hospital Sector In Northern-Norway - Analyses Based On Updated Regional Performance Database

    Oct 1, 2017, 00:00

  • Inpatient Medication Errors And Pharmacist Intervention At Ministry Of Health Public Hospital In Riyadh, Saudi Arabia

    Oct 1, 2017, 00:00

  • Treatment Patterns of Chronic Heart Failure (CHF) In Argentina

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Indacaterol/Glycopyrronium in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Colombia

    Oct 1, 2017, 00:00

  • Various Strategies of Management of Patients With Diabetic Polyneuropathy- Modeling of Clinical Outcomes And Pharmacoeconomic Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Apremilast for the Treatment of Active Psoriatic Arthritis In Greece

    Oct 1, 2017, 00:00

  • Impact Of Multi-Drug Resistance On HTA Assessment Of Antibiotics In France, Germany, United Kingdom

    Oct 1, 2017, 00:00

  • Involvement Of Community Pharmacists In Public Health Priorities- A Multi-Center Descriptive Survey In Ethiopia

    Oct 1, 2017, 00:00

  • Efecto Del 1B8 EN EL Tratamiento De Pacientes Con Linfoma No Hodgkin Cd20+

    Oct 1, 2017, 00:00

  • Deflazacort or Prednisone Treatment for Duchenne Muscular Dystrophy- A Meta-Analysis of Disease Progression Rates in Recent Multicenter Clinical Trials

    Oct 1, 2017, 00:00

  • Patient Empowerment for Healthcare Decision-Making Assessing Oncology Innovation Through Multicriteria Decision Analysis

    Oct 1, 2017, 00:00

  • Multiplatform Tumor Profiling Delivers Value Based Health Care In Refractory Cancer Patients

    Oct 1, 2017, 00:00

  • Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Mexico

    Oct 1, 2017, 00:00

  • Healthcare Insurance Spending At Year 2 Between Treatment Groups Following Diagnosis Of Nontuberculous Mycobacterial Lung Disease In The US

    Oct 1, 2017, 00:00

  • The French Compassionate Use Of Medicinal Products Programme- A Drastic Increase Of Expenditure Over The 2012-2016 Period

    Oct 1, 2017, 00:00

  • Metanálise De Segurança Do Tratamento Medicamentoso De Pacientes Com Transtorno Do Déficit Da Atenção com Hiperatividade E Ansiedade

    Oct 1, 2017, 00:00

  • Survival Differences In Heart Failure Patients With And Without Iron Deficiency/Anemia And By Oral And Intravenous Iron Treatment

    Oct 1, 2017, 00:00

  • Costo-Utilidad De La Vacunación Contra Varicela En Perú

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Low-Dose Methoxyflurane For The Treatment of Moderate-To-Severe Trauma Pain In Sweden

    Oct 1, 2017, 00:00

  • Myocardial Revascularization- Comparative Cost Study In South America Health Care System

    Oct 1, 2017, 00:00

  • Women's Preferences- A Discrete-Choice Experiment For Treatment of Menorrhagia with Uterus-Preserving Therapy

    Oct 1, 2017, 00:00

  • Real-World Cost Effectiveness Comparison Of Symbicort Turbuhaler And Duoresp Spiromax In UK Patients With Asthma Or Chronic Obstructive Pulmonary Disease

    Oct 1, 2017, 00:00

  • Deep Brain Stimulation For Parkinson's Disease- Comparison Between Unilateral And Bilateral Implantation

    Oct 1, 2017, 00:00

  • Suspected Adverse Reactions (SARS) To Systemic Glucocorticoid Usage In Dogs In Primary Veterinary Practice In The UK

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of Tacrolimus XL in Comparison to Generic Tacrolimus from the Public Healthcare Sector in Mexico

    Oct 1, 2017, 00:00

  • Migraine Burden and Costs- A Nationwide Population-Based Controled Cohort Study Using The French EGB Database

    Oct 1, 2017, 00:00

  • Outcome Measures used to Assess Interventions for Asthma Control- A Systematic Review

    Oct 1, 2017, 00:00

  • A Review Of Methods For Item Selection In The Development Of A Descriptive System For Quality Of Life Instrument

    Oct 1, 2017, 00:00

  • Sink or Swim- How Can Asthma Biologics Successfully Sail the Rough Waters of EU5 Market Access?

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Fingolimod for The Treatment Multiple Sclerosis In Korea

    Oct 1, 2017, 00:00

  • Factors Associated with Quality of Life(QOL) In Peripheral Arterial Disease(PAD) Patients in Korea- Results from Pad Outcomes Research(OR)

    Oct 1, 2017, 00:00

  • Spirometry Comparison Of Lung Fuction Between Coalminers And Non-Coalminers

    Oct 1, 2017, 00:00

  • Developing a Multi-Criteria Framework for Innovation and Biologic Drugs Assessment Decision Making in Egypt

    Oct 1, 2017, 00:00

  • The Cost-Effectivness Analysis of The Latent Tuberculosis Infection Screening For Adults 40 Years old In South Korea

    Oct 1, 2017, 00:00

  • Patients With High Comorbidity And Transitioning To Dialysis At High Risk Of Suboptimal Antihypertensive Medication Prescription Use- Results From A Brazilian National Cohort (BRAZPD) Of Peritoneal Dialysis

    Oct 1, 2017, 00:00

  • Determination Of Needs And Priorities In Order To Better Organization Of Antenatal Courses

    Oct 1, 2017, 00:00

  • Impact of Drug Related Problems on Blood Pressure Control In Patients With Hypertension In Indonesian Primary Health Care

    Oct 1, 2017, 00:00

  • A Snapshot of Medication Adherence Across Three European Countries- Application of Common Methodology

    Oct 1, 2017, 00:00

  • The Burden And Cost Of Illness Of Gout In Secondary Care In England

    Oct 1, 2017, 00:00

  • Comparing Surgical Therapy and Hormonal Therapy In Incidence Of Cardiovascular Disease Among Prostate Cancer Patients In Korea

    Oct 1, 2017, 00:00

  • Financial Optimization in The Treatment for Rheumathoid Artritis in Patients Receiving Conventional Dmard Therapy

    Oct 1, 2017, 00:00

  • A Typology-Based Decisional Framework To Support Market Access And Reimbursement Decisions For Personalised Medicines

    Oct 1, 2017, 00:00

  • Cost Benefit Analysis in The Treatment of Severe Osteoporosis from The Public Healthcare System Perspective in Mexico

    Oct 1, 2017, 00:00

  • Alternative Reimbursement Models for High Cost Health Technologies

    Oct 1, 2017, 00:00

  • Disease-Specific Patient-Reported Outcome Instruments In Sickle Cell Disease- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Cost-Consequences Of Using Fluciclovine (F 18) For The Diagnosis And Staging Of Recurring Prostate Cancer

    Oct 1, 2017, 00:00

  • Technical Challenges in Cost-Effectiveness Analysis for Oncology Treatments- Identifying Frequent Issues in Modelling From Nice Perspective

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis of Dutasteride Plus Tamsulosin Combination Therapy Versus Tamsulosin Monotherapy in The Treatment of Benign Prostatic Hyperplasia in Iran

    Oct 1, 2017, 00:00

  • Treatment Pattern Of Patients Diagnosed With Prostate Cancer In Korea- A Trend Analysis Using Nationwide Health Insurance Database

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ponatinib in The Treatment of Patients With Accelerated or Blast Phase - Chronic Myeloid Leukemia in Greece

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis of Artificial Urinary Sphincter Versus Advance Male Sling In Post Prostatectomy Stress Urinary Incontinen A Canadian Healthcare Perspective

    Oct 1, 2017, 00:00

  • A Systematic Review of Pharmacoeconomic Evaluation of Erlotinib in The First-Line Treatment of Advanced Non-Small Cell Lung Cancer

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Brazil

    Oct 1, 2017, 00:00

  • How Should We Test For Pre-Term Labour? An Economic Model And Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Healthcare Resource Use and Costs In Patients With Major Depressive Disorder Switching From A Generic To A Branded Antidepressant

    Oct 1, 2017, 00:00

  • Health Loss Due To Market Access Delays And Reimbursement Restrictions In First-Line EGFR-Positive Non-Small Cell Lung Cancer In The EU5 Countries

    Oct 1, 2017, 00:00

  • Preferences of The General Population To Avoid Oral Health Outcomes- Results of A Bayesian Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Population Health Impact of Omalizumab over 15 Years of Experience in Moderate to Severe Allergic Asthma

    Oct 1, 2017, 00:00

  • Patient’s Journey Through Acute Myeloid Leukemia (AML)- Understanding AML’s Humanistic Impact Through an International Patient-Centric Qualitative Study

    Oct 1, 2017, 00:00

  • Trastuzumab As A Therapy Versus Other Treatment Regimens In Patients With HER2 Positive Breast Cancer- A Systematic Review of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Economic Impact Of Moderate And Severe Neurotrophic Keratitis In Italy

    Oct 1, 2017, 00:00

  • Quality of Life Assessment in Ild – A Comparison of EQ-5D with The Disease-Specific K-Bild

    Oct 1, 2017, 00:00

  • Screening For Asymptomatic Atrial Fibrillation- Its Effectiveness And Cost-Effectiveness Of Repeated Ecg In Poland

    Oct 1, 2017, 00:00

  • Effects of Propofol Versus Other General Anesthesia in Children Younger Than 3 Years of Age- A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • The use of Scientific Evidence to Support Judicial Decisions

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Empagliflozin In Patients With Type 2 Diabetes Mellitus At High Cardiovascular Risk In Poland

    Oct 1, 2017, 00:00

  • Analysis of Using Irp as A Launch Price Setting Mechanism

    Oct 1, 2017, 00:00

  • Cognitive assessments on portable devices- A comparison between phones and tablets

    Oct 1, 2017, 00:00

  • Análisis De Costo Efectividad Del Uso De Budesonida/Formoterol Frente A Salmeterol/Fluticasona, En Pacientes Con Asma Moderada Y Severa En Colombia

    Oct 1, 2017, 00:00

  • Análise De Custo-Efetividade Do Tratamento Diretamente Observado Da Tuberculose

    Oct 1, 2017, 00:00

  • Estimates of PFS, TTNT Per Treatment Line and their Relationship for Multiple Myeloma Patients

    Oct 1, 2017, 00:00

  • Real-World Management And Outcomes Of Patients With Multiple Myeloma In Romania And Poland

    Oct 1, 2017, 00:00

  • Use Of Pragmatic Clinical Trials To Support Drug Launch

    Oct 1, 2017, 00:00

  • Obinutuzumab vs. Ibrutinib in the Treatment of Treatment-Naïve Patients with Chronic Lymphocytic Leukemia —A Cost-Comparison Study in Colombia

    Oct 1, 2017, 00:00

  • Efficacy Of Antioxidant Supplements On Prevention And Amelioration Of Cisplatin-Induced Nephrotoxicity- A Systematic Review And Meta-Analysis Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Posterior Capsule Opacification After Cataract Extraction And Related Healthcare Costs In Germany – A Claims Data Analysis On The Impact Of The Implanted Type Of Intraocular Lenses

    Oct 1, 2017, 00:00

  • Tools For Improving Efficiency In Clinical Management And Safety Of Hypertensive Patients. Efigie-hta Project

    Oct 1, 2017, 00:00

  • Identifying Evidence on The Cost-Effectiveness of Treatments And Costs/Resource Use And Quality of Life of Patients with Follicular Lymphoma And Marginal Zone Lymphoma- Systematic Reviews

    Oct 1, 2017, 00:00

  • Would a Two-Dose Rotavirus Vaccine Improve Health Outcomes While Reducing Costs in the Sultanate of Oman?

    Oct 1, 2017, 00:00

  • The Impress Of Pharmacoeconomics In Pricing Decisions In IFDA

    Oct 1, 2017, 00:00

  • Cost-Savings Due To Implementation of A Screening Algorithm For Diagnosis of Rheumatoid Arthirits in Colombia

    Oct 1, 2017, 00:00

  • Growth of National Health Insurance Expenditure Related To Antidiabetics And Their Projections Up Until 2020

    Oct 1, 2017, 00:00

  • Antithrombotic Treatments in Patients with Acute Ischemic Stroke and Non-Valvular Atrial Fibrillation Before Introduction of Non-Vitamin K Antagonist Oral Anticoagulants Into Practice in Korea

    Oct 1, 2017, 00:00

  • Costs Associated With Transthyretin Familial Amyloid Polyneuropathy Progression

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Secukinumab use Versus Tnf-Α Inhibitors, in Patients with Ankylosing Spondilytis

    Oct 1, 2017, 00:00

  • Antibiotics Treatment Patterns As A Costs And Resource Utilization Predictor Among Patients Submitted To Bariatric Surgery- Analysis of A Large Health Insurance Claims Database

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ponatinib in The Treatment of Patients with Acute Lymphoblastic Leukemia with Philadelphia Chromosome Positive (PH+ ALL), Suitable for Allogeneic Stem Cell Transplant, in Greece

    Oct 1, 2017, 00:00

  • Impact of Cytomegalovirus Infection and Treatment on Patient-Reported Outcomes In Haematopoietic Cell Transplant Recipients

    Oct 1, 2017, 00:00

  • Assessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo- Preliminary Data

    Oct 1, 2017, 00:00

  • Epidemiological Estimates and Treatment Practice Pattern in Polycythemia Vera Patients in Turkey- Results Based on an Expert Panel

    Oct 1, 2017, 00:00

  • The Resource And Cost Consequences Of Using Antibiotic Coated Intramedullary Nails Compared To Non-Coated Nails In Open Tibia Fractures Across Four European Centres

    Oct 1, 2017, 00:00

  • Differences And Decision Drivers In The Hta-Outcome Category Lower Benefit Between Iqwig And G-Ba Assment In The German Amnog Process

    Oct 1, 2017, 00:00

  • Real-World Treatment Patterns And Time To Discontinuation In Rheumatoid Arthritis Patients In The US

    Oct 1, 2017, 00:00

  • Impact Of Using Overall Survival Or Progression-Free Survival In Outcomes-Based Pricing Arrangements

    Oct 1, 2017, 00:00

  • The Role Of Disability On Early Retirement

    Oct 1, 2017, 00:00

  • The Effect of Value Based Insurance Designs on Costs- A Systematic Review

    Oct 1, 2017, 00:00

  • An Accessible Comparison Of Traditional Statistical And Machine Learning Approaches To Analysis Of Real World Data- Which, When And Why?

    Oct 1, 2017, 00:00

  • Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Diabetes Mellitus In Colombian Population In The Year 2016

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Study To Evaluate Insulin Glargine Compared With NPH Insulin In Patients With Type 2 Diabetes Uncontrolled With Oral Anti-Diabetic Agents In Hong Kong

    Oct 1, 2017, 00:00

  • Table of Contents

    Oct 1, 2017, 00:00

  • Methodological Analyses Of Budget Impact Models Submitted To The Haute Autorité De Santé (HAS) (French National Authority For Health)

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Fulvestrant 500 Mg in Endocrine Therapy-Naïve Women with Hormone Receptor-Positive Advanced Breast Cancer in The UK

    Oct 1, 2017, 00:00

  • Immunobiological Use Profile In The Service of Rheumatology of A Heatlhcare Provider

    Oct 1, 2017, 00:00

  • Evaluation of the Cost Effectiveness of the Treatment of Mild and Moderate Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Alternative Sources For Health Care Funding- Public Health Taxes In Hungary Between 2011-2016

    Oct 1, 2017, 00:00

  • Could Embase Emtree Index Search Terms Be Focused To Reduce Numbers To Screen In Clinical Systematic Reviews?

    Oct 1, 2017, 00:00

  • How Far Equity Has Been Achieved in the Indonesian Universal Health Coverage?

    Oct 1, 2017, 00:00

  • Cost Assessment Of Acquired Resistant Bacterial Infection In A Hospital In The Dominican Republic

    Oct 1, 2017, 00:00

  • Generating Patient Insights In Dry Eye Disease With A Social Media Listening Study

    Oct 1, 2017, 00:00

  • Personalised Health Definitions – A New Supplemental Framework to Interpret Individuals’ Responses on the EQ-5D-VAS

    Oct 1, 2017, 00:00

  • Cost Analysis of Lung Cancer in China

    Oct 1, 2017, 00:00

  • Lifetime Risk of Revision Following Joint Replacement- Evidence From Routinely-Collected Data

    Oct 1, 2017, 00:00

  • Comparison Of Hospital Resource Utilization Between Elective And Emergent Admissions Among Patients Undergoing Inpatient Colorectal Surgery

    Oct 1, 2017, 00:00

  • The Coordinated Management Of Patient With Mental Illness In Spain By Hospital, Primary Care And Community Pharmacists (3PH), A Resource Optimization Model

    Oct 1, 2017, 00:00

  • Avaliação Da Indicação Terapêutica Da Metilprednisolona No Tratamento Adjunto De Pessoas Portadoras De Pneumonia Por Pneumocystis Carinii

    Oct 1, 2017, 00:00

  • Second-Line Treatment for Steroid-Refractory Graft-Versus-Host Disease with Mesenchymal Stromal Cells. A Conceptual Disease Model

    Oct 1, 2017, 00:00

  • Prevalence of Anticonvulsants Utilization at a Tertiary Hospital in Southeast Nigeria; Bridging the Gaps Between Facilities Outcomes and Policies Through Evidence-Based Reports

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Insulin Pumps Versus Multiple Daily Insulin (MDI) Injection In Type 1 Diabetes In India From Societal Perspective

    Oct 1, 2017, 00:00

  • Comparative Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants (NOACS) And Warfarin In The Scottish Atrial Fibrillation Population- The Value of Real World Evidence

    Oct 1, 2017, 00:00

  • Penetration of Peripheral Vascular Interventions in Hungary

    Oct 1, 2017, 00:00

  • Time to Access- Too Fast, Too Slow, or Just Right? An Evolving Public Reimbursement Landscape of Drugs For Rare Diseases In Canada

    Oct 1, 2017, 00:00

  • Health Technologies' Taxonomy and Challenges To Apply The Assessment

    Oct 1, 2017, 00:00

  • Estratégias Intitucionais Como Mecanismo De Racionalização Das Demandas Judiciais De Medicamentos

    Oct 1, 2017, 00:00

  • Real World Data On Labor Procedures In The Brazilian Unified Health System (SUS). An Eight Years Retrospective Database Study

    Oct 1, 2017, 00:00

  • Medication Adherence and Quality of Life of Uncontrolled Hypertension Patients in Korea

    Oct 1, 2017, 00:00

  • Implementation Of A Data Mining Model Within A Monitoring Web-Based Tool To Assess HER2 Breast Cancer Status Using The Her-France Real World Database

    Oct 1, 2017, 00:00

  • Quality of Life in Patients with Chronic Heart Failure in Slovak Republic

    Oct 1, 2017, 00:00

  • Regional Differences In Potential Savings For The Medical Treatment Of Advanced Prostate Cancer In The German Health Care System

    Oct 1, 2017, 00:00

  • Cost Of Hospital Treatment For Severe And Moderate-To-Severe Influenza In Russia

    Oct 1, 2017, 00:00

  • Conceptualization, Development, And Internal And External Validation of A ‘Whole Disease’ Model for Chronic Obstructive Pulmonary Disease

    Oct 1, 2017, 00:00

  • Changes in acute medication cost observed in cluster headache patients treated with sphenopalatine ganglion (SPG) stimulation- a U.K. NHS-specific analysis based on data from the pathway R1 registry

    Oct 1, 2017, 00:00

  • Health Economic Evaluation Of Elective Cardioversion Of Atrial Fibrillation With Rivaroxaban Versus Vitamin K Oral Antagonists

    Oct 1, 2017, 00:00

  • A Conceptual Model of The Economics of Visualization In Diagnostics and Surgery

    Oct 1, 2017, 00:00

  • Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C- A Decision Analysis from The Perspective of The Brazilian Public Health System

    Oct 1, 2017, 00:00

  • Barriers To Effective Treatment Of Patients With Cll In Poland In Comparison To The United Kingdom

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization And Costs For Total Hip Arthroplasty- Benchmarking The Anterior Approach In The Medicare Population

    Oct 1, 2017, 00:00

  • Fractional Polynomial NMA Models For Survival Analyses- Results From A Simulation Study

    Oct 1, 2017, 00:00

  • Impact of Comorbidities on The Risk And Cost of Hospitalization In Hiv-Infected Patients- Real World Data From The Abruzzo Region

    Oct 1, 2017, 00:00

  • Reported Limitations In Economic Models for Treatments of Schizophrenia- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • The Role of Community Pharmacists in Patient Counselling and Health Education- A Survey of Their Knowledge and Level of Involvement in Relation to Type 2 Diabetes Mellitus

    Oct 1, 2017, 00:00

  • Access Perceptions- A Key Driver Of Non-Small Cell Lung Cancer (NSCLC) Targeted Therapy Prescription In Russia

    Oct 1, 2017, 00:00

  • Assessing the Consistency in Reporting of Adverse Events Across Data Sources for Multiple Myeloma Treatment

    Oct 1, 2017, 00:00

  • Comparison Of Elderly Care Recipients’ Social Care-Related Quality Of Life (SCRQOL) With Health Related Quality Of Life (HRQOL) In Japan

    Oct 1, 2017, 00:00

  • How Will Proposed Changes To The Nice Highly Specialised Technology Evaluation Process Impact Patient Access To Innovative Drugs for Rare Diseases?

    Oct 1, 2017, 00:00

  • Cost Associated with Self-Expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement in Latin America

    Oct 1, 2017, 00:00

  • The Efficiency Path To Universal Health Coverage- Derivation Of Cost-Effectiveness Thresholds Based On Health Expenditures And Life Expectancy. Updated Country-Level Estimates For 194 Countries

    Oct 1, 2017, 00:00

  • Real Life Cost of Treatment and Follow-Up in Pancreatic Adenocarcinoma Patients Treated At The Antwerp University Hospital (UZA), Belgium

    Oct 1, 2017, 00:00

  • Pattern Of Anti-Infective Drugs Use In A Tertiary Healthcare Facility In Nigeria

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Venetoclax For Treatment Of Refractory/Relapsed Chronic Lymphocytic Leukemia With Or Without 17P Deletion In Bulgaria

    Oct 1, 2017, 00:00

  • Indirect Comparisions Presented In German Benefit Assessments – Status Quo and Quo Vadis?

    Oct 1, 2017, 00:00

  • Comparing Inhaled Corticosteroids and Long-Acting Beta Agonists Combination To Inhaled Corticosteroids on Risk of Ischemic Cardiovascular Diseases in Patients with Asthma

    Oct 1, 2017, 00:00

  • Assessment Of Knowledge And Perceived Practices Of Antimicrobial Stewardship Among Malaysian Future Healthcare Professionals

    Oct 1, 2017, 00:00

  • What Underlies The Observed Hospital Volume-Outcome Relationship?

    Oct 1, 2017, 00:00

  • Consulta Pública Como Instrumento De Diálogo E Negociação Entre Indústria E Governo

    Oct 1, 2017, 00:00

  • Quality Assured Use of Pharmaceuticals- Does German Gba Follow Ema?

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Alternative Measles-Mumps-Rubella Childhood Vaccination Schedules In Denmark

    Oct 1, 2017, 00:00

  • The Impact of Pharmacist-LED Medication Therapy Management on Medication Adherence in Patients with Type 2 Diabetes Mellitus- A Randomized Controlled Study

    Oct 1, 2017, 00:00

  • Feasibility Assessment- The Impact of A Reduced Operating Room Footprint System On The Resources Required For Instrument Management In Deformity Surgery From An Italian Hospital Perspective

    Oct 1, 2017, 00:00

  • Centralization And Complexity Of Drug Market Access Process Across Italian Regions

    Oct 1, 2017, 00:00

  • Long-Term work Productivity improvement from Phase 3 Baricitinib Ra-Beam Study- Latin American Subgroup Analysis

    Oct 1, 2017, 00:00

  • Systematic Review Of Pivotal Studies Of Oncology Drugs Authorized In Italy Since 2013- Correlation Between Studies’ Main Characteristics And Time To Patient

    Oct 1, 2017, 00:00

  • The Comparative Pharmacoeconomic Analysis Of Using Absorb Bioresorbable Vascular Scaffold System For Patients With St Segment Elevation Myocardial Infarction (STEMI)

    Oct 1, 2017, 00:00

  • Consumers’ Assessment On Integrated Delivery System In Remote Areas In Taiwan

    Oct 1, 2017, 00:00

  • Management Of Duchenne Muscular Dystrophy (DMD)- Results From A Global Survey Of Healthcare Providers From Nine Countries

    Oct 1, 2017, 00:00

  • Retrospective Analysis of The Ceesp Efficiency Opinions and Eligibility Criteria for Assessment Since Its Creation

    Oct 1, 2017, 00:00

  • Comparison Of Catheter-Related Complications Between Manually-Prepared Saline Flush Syringes And Commercially Available Pre-Filled Saline Flush Syringes

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation of A Two-Dose Human Papillomavirus Vaccination Schedule in Colombia

    Oct 1, 2017, 00:00

  • Real-World Treatment Patterns Among Patients Initiating on Statins in England

    Oct 1, 2017, 00:00

  • Safety And Efficacy of Osimertinib As A Therapy In Patients With Egfr T790M Positive Non Small Cell Lung Cancer Patients- A Systematic Review

    Oct 1, 2017, 00:00

  • Cost Burden Associated with Advanced Non-Small Cell Lung Cancer (A-NSCLC)- Impact of Disease Stage

    Oct 1, 2017, 00:00

  • Occurrence Of Skeletal-Related Events (SRE) In Patients With Solid Tumors (ST) And Multiple Myeloma (MM) In Germany- Early Versus Late Initiation of Sre Preventative Agents (SPA)

    Oct 1, 2017, 00:00

  • Antiviral Medicines Assessment- What Is Driving High Clinical Added Value In France?

    Oct 1, 2017, 00:00

  • The Burden of Genital Warts In Latin America- A Review of the Evidence

    Oct 1, 2017, 00:00

  • Evaluación Económica De Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir En El Tratamiento De La Infección Crónica Por Hepatitis C En Uruguay

    Oct 1, 2017, 00:00

  • The Multi-Criteria Decision Analysis in the Priority Setting of Emerging Medicines

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Ultrasound Screening, Cancer Patients, To Detect Asymptomatic Thrombosis

    Oct 1, 2017, 00:00

  • An Analysis Of HTA And Reimbursement Processes In Eunethta Partner Countries- Implications For Implementing HTA Cooperation

    Oct 1, 2017, 00:00

  • The Role Of Companion Diagnostics In HTAS Of Drugs In France, Germany And The UK

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Vedolizumab for the Treatment of Adult Patients with Moderately-to-Severely Active Ulcerative Colitis in Russia

    Oct 1, 2017, 00:00

  • Ecocardiograma Sob Estresse Com Dobutamina- Alternativa Econômica E Exeqüível Na Avaliação De Risco Cardiovascular Pré Transplante Renal

    Oct 1, 2017, 00:00

  • Burnout Syndrome among Healthcare Professionals working in Gondar University Hospital, Northwest Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Tocilizumab, Infliximab and Etanercept Drugs for The Treatment of Rheumatoid Arthritis in Ecuador

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Diagnostic Technologies for Dementia- A Systematic Review of Economic Evaluations

    Oct 1, 2017, 00:00

  • Hypertension Medication Access and Self-Management Among the Elderly by Education- Insights from the 2013 USA Medicare Current Beneficiary’s Survey

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece

    Oct 1, 2017, 00:00

  • Systematic Review and Meta-Analysis of The Efficacy And Safety Of Amfepramone and Mazindol As A Monotherapy for The Treatment of Obese or Overweight Patients

    Oct 1, 2017, 00:00

  • Applying The Institute For Clinical And Economic Review’s (ICER) Methodology To Canada- An Improved Way To Take Into Consideration Drug Affordability Challenges?

    Oct 1, 2017, 00:00

  • Evaluation Of New Biologic Starts And Switching Among Real-World Rheumatoid Arthritis Patients In The United States

    Oct 1, 2017, 00:00

  • The First EQ-5D-5L Value Set In Central And Eastern Europe

    Oct 1, 2017, 00:00

  • Case-Control Study on Risk Factors for Cancer from the Epidemiological Survey Carried Out on Beneficiaries of a Private Health Care Plan in Brazil- 10 Years of Follow-Up

    Oct 1, 2017, 00:00

  • Analyzing Ovarian Cancer Recurrence After Tumor Resection in Other Sites Through The Brazilian Public Healthcare Claim Databases (DATASUS)

    Oct 1, 2017, 00:00

  • Effectiveness of a Pharmacist-Delivered Smoking Cessation Program in the State of Qatar- A Randomized Controlled Trial

    Oct 1, 2017, 00:00

  • Healthcare Costs Of Patients With Acute And Chronic Graft-Versus-Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation In Belgium- A Retrospective Data Collection And Analysis

    Oct 1, 2017, 00:00

  • Evaluation of Safety and Efficacy of Propofol for Procedural Sedation in Pediatric Population- A Meta-Analysis

    Oct 1, 2017, 00:00

  • Correlation of Minimal Clinically Important Differences Between Patient Reported Outcome Measures Related To Spinal Surgery

    Oct 1, 2017, 00:00

  • The Cost Of Prescribing Direct Oral Anticoagulants (DOACS) – There Is A Drug Cost But What Else?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Alemtuzumab In The Treatment of Relapsing Forms of Multiple Sclerosis In The United States and Societal Spillover Effects

    Oct 1, 2017, 00:00

  • Percepción De La Competencia En El Mercado De Medicamentos Esenciales Y Huérfanos En Panamá

    Oct 1, 2017, 00:00

  • Quantifying Standard Of Care (SOC) Hospital-Related Resource Utilisation For Metastatic Uveal Melanoma (MUM) Patients In Nhs England (NHSE) Using The Hospital Episodes Statistics (HES) Dataset

    Oct 1, 2017, 00:00

  • Bibliometric Analysis of the Worldwide Research Productivity on Oral Health Related Quality of Life (Ohrql)

    Oct 1, 2017, 00:00

  • Health Care Resource Use (HCRU) Due To Bleeding Related Episodes (BRE) In Patients With Immune Thrombocytopenic Purpura (ITP) Receiving Eltrombopag (EPAG), Romiplostim (ROMI), Or Rituximab (RITUX)- Real World Evidence (RWE) From 27 US Insti ...

    Oct 1, 2017, 00:00

  • Optimal Usage of Sacubitril/Valsartan For Heart Failure Treatment In Canada Potentially Reduces Mortality, Hospitalizations And Early Discharge Re-Admissions

    Oct 1, 2017, 00:00

  • Economic Burden of Chronic Respiratory Diseases In Austria

    Oct 1, 2017, 00:00

  • Budget Impact of A New, First-In-Class Triple Fixed Dose Combination Therapy For COPD Patients

    Oct 1, 2017, 00:00

  • Idiopathic Pulmonary Fibrosis- A Cost Of Illness Analysis In Greece

    Oct 1, 2017, 00:00

  • Integrated 2 Screw Cepahlo-Medulary Device Reduces Device Related Post-Operative Complications and Pain After Intertrochanteric Fractures, Evidence From a Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Method Of Extrapolation- Estimation Of The Impact Of The Proportional Hazard Assumption On The Efficacy Estimation

    Oct 1, 2017, 00:00

  • Model Types Submitted To Ni What Is Considered Appropriate By Evidence Review Groups?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Daratumumab in Heavily Pre-Treated Multiple Myeloma Patients for The Italian Healthcare System

    Oct 1, 2017, 00:00

  • Influence Of Disease Familiarity On Implied Time Preferences For Seizure Frequency Reduction

    Oct 1, 2017, 00:00

  • Network Meta-Analysis of Treatments For Unresectable Hepatocellular Carcinoma

    Oct 1, 2017, 00:00

  • Inclusion Of Safety/ADR-Related Outcomes In Economic Evaluations For Seasonal Influenza Vaccines- A Review Of Available Studies

    Oct 1, 2017, 00:00

  • Quality of Life in Patients with Kidney Transplantation in Czech Republic

    Oct 1, 2017, 00:00

  • Assessing The Disease Course And Treatment of Psoriatic Arthritis (PSA) In Canada

    Oct 1, 2017, 00:00

  • Patient Characteristics and Disease Burden of Psoriasis In Mexico- A Real-World Physician and Patient Survey

    Oct 1, 2017, 00:00

  • Persistence, Compliance And Bisphosphonate Switching In Patients With Multiple Myeloma (MM) In Germany

    Oct 1, 2017, 00:00

  • Cost Analysis of Pre-Dialysis- A Model in the Brazilian context

    Oct 1, 2017, 00:00

  • Wound Management In Diabetic Foot Ulcer (DFU) - Incremental Cost-Analysis Of Treating Diabetic Neuropathic Foot Lesions With Adjunct Hemoglobin Contact Spray In Germany

    Oct 1, 2017, 00:00

  • Financial Impact of Introducing Sc Trastuzumab (HERCEPTIN) Versus Currently Used IV Trastuzumab (HERCEPTIN) on The Budgets of Different Hospitals Across Kingdom of Saudi Arabia (KSA)

    Oct 1, 2017, 00:00

  • Predicting The Future Costs of Cancer Based on Register Data and Innovation Trends

    Oct 1, 2017, 00:00

  • An Exploration of the Methodology of Published Systematic Literature Reviews on “Burden of Disease”

    Oct 1, 2017, 00:00

  • Evaluating The Annual Cost Per Response Rate of Pirfenidone And Nintedanib For The Treatment of Patients With Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Exploratory Analysis Of The Reasons For Creating Worldwide Translations Of Patient Reported Outcome Instruments

    Oct 1, 2017, 00:00

  • The Cost Of Dialectic Behaviour Therapy (DBT) For People Diagnosed With Borderline Personality Disorder (BPD)- A Review of The Literature

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Ivabradine In The Treatment Of Chronic Heart Failure From The Mexican Perspective

    Oct 1, 2017, 00:00

  • Treatment with Biological Agents Among Patients with Ankylosing Spondylitis in Germany- A Claims Data Analysis

    Oct 1, 2017, 00:00

  • 2017 Update of Recent Trends in Multiple Sclerosis-Related Health Technology Assessment Decisions- An Assessment of Five Countries

    Oct 1, 2017, 00:00

  • Estimación De Costos De Los Servicios De Hemodiálisis Crónica Y Hemodiafiltración EN Argentina

    Oct 1, 2017, 00:00

  • Compliance And Treatment Satisfaction With Biological Treatments For Systemic Juvenile Idiopathic Arthritis (SJIA)

    Oct 1, 2017, 00:00

  • Measuring The Intensity Of Care Coordination For Blood Cancer Patients In France

    Oct 1, 2017, 00:00

  • Cost Per Median Overall Survival Associated with Abiraterone Acetate and Enzalutamide For Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer in Colombia

    Oct 1, 2017, 00:00

  • Calculating The Return On Investment For Ifn-Free DAAS- The Case Of Greece

    Oct 1, 2017, 00:00

  • Rate of Hospitalization Due To Adverse Event and Length of Stay for Atezolizumab in Second and Third Line Metastatic Non-Small Lung Cancer (NSCLC) Using Phase 3 Oak Study

    Oct 1, 2017, 00:00

  • Testing The Beacon Tool With Health Economists And Clinicians – Is There Consistency In Its Application?

    Oct 1, 2017, 00:00

  • Estimation Of The Health-Related Quality Of Life Benefits Of Treatment For Spinal Muscular Atropy (SMA)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Lidocaine Medicated Patch Compared with Pregabalin and Gabapentin for the Treatment of Postherpetic Neuralgia an Diabetic Polyneuropathy in Colombia

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Deep-Vein Thrombosis In Europe – Healthcare Resource Utilization And Productivity Loss

    Oct 1, 2017, 00:00

  • How Does The Scottish Medicines Consortium Assess The Value Of Orphan And Ultra-Orphan Drugs?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of PET/CT In Pre-Operative Staging Of Pancreatic Cancer- An Economic Evaluation Of The PET-PANC Cohort Study

    Oct 1, 2017, 00:00

  • Incidence and Costs of Hypoglycemia In Diabetes Patients Initiated On Basal Insulin- A Population-Based Study

    Oct 1, 2017, 00:00

  • Update on Impact of The Additional Benefit Extent of Orphan Drugs on Price Negotiations In The German Outpatient Sector

    Oct 1, 2017, 00:00

  • Prevalence And Treatment Cost of Non-Communicable Diseases Related To Smoking In Indonesia

    Oct 1, 2017, 00:00

  • Can The Barthel IndeX (BI) Be Reliably Used Within Economic Evaluation? An Examination Of The Complementarity Of The BI And The Euroqol 5 Dimensions 3 Level (EQ-5D-3L)

    Oct 1, 2017, 00:00

  • Systematic Review of Observational Studies of Interferon-Free Treatments for Chronic Hepatitis C

    Oct 1, 2017, 00:00

  • Understanding The Barriers To Vaccine Access And Uptake In EU5- Rotavirus Vaccination Case Study

    Oct 1, 2017, 00:00

  • Assessing the Burden of Disease in Peripheral and Axial Spondyloarthritis in Mexico and Brazil

    Oct 1, 2017, 00:00

  • “It’s All Relative” – Exploring The Challenges During Cultural Adaptation Of Family Names In PRO (Patient Reported Outcomes) Questionnaires

    Oct 1, 2017, 00:00

  • Impact of Comprehensive Genomic Profiling of Patients With First Line Non-Small Cell Lung Cancer In The UK

    Oct 1, 2017, 00:00

  • Resultados Econômicos Da Gestão Clínica De Antimicrobianos Realizados Por Uma Operadora De Plano De Saúde Em Fortaleza-Brasil

    Oct 1, 2017, 00:00

  • Patient Burden of Rheumatoid Arthritis- Results of a Global Systematic Literature Review on Disability, Work Disruption, and Functional Capability in the Real World

    Oct 1, 2017, 00:00

  • Economic Analysis Of The Lutonix® 035 Drug Coated Balloon Pta Catheter For The Treatment Of Vascular Access Stenosis In Patients With Arteriovenous Fistulas

    Oct 1, 2017, 00:00

  • Network Meta-Analysis In The Evaluation of Vaccines

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A 0.2 Μg/Day Fluocinolone Acetonide (FAC) Implant In The Treatment Chronic Diabetic Macular Oedema (DMO) In The UK

    Oct 1, 2017, 00:00

  • Costs of Illness Progression for Different Multiple Sclerosis Phenotypes- A Population-Based Study in Sweden

    Oct 1, 2017, 00:00

  • Costos De La Hipoglucemia En Colombia

    Oct 1, 2017, 00:00

  • Trends In Oncology Appraisal Decisions- A Comparison Between The National Institute For Health And Care Excellence (NICE) And The Scottish Medicines Consortium (SMC)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Additional Vaccination of Boys Against HPV In Germany

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Empagliflozin (Jardiance®) In The Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) In Turkey Based Empa-Reg Outcome Data

    Oct 1, 2017, 00:00

  • An Economic Evaluation of A Psychoeducational Suicide Intervention Programme

    Oct 1, 2017, 00:00

  • One-Center Analysis of Cost Associated With Acromegaly Management In Poland

    Oct 1, 2017, 00:00

  • A Survey On The Society's Awareness Level On Aids In Turkey

    Oct 1, 2017, 00:00

  • A Systematic Review On Lifestyle Change Interventions Performed By Health Care Professionals Targeting Blood Pressure In Hypertensive Patients

    Oct 1, 2017, 00:00

  • High-Cost Oncology Drugs in Brazil and Mexico- Access Differences Between the Public and Private Settings

    Oct 1, 2017, 00:00

  • The Burden of Urothelial Carcinoma for the Brazilian Public Health System- A National Retrospective Analysis From 2013 TO 2016

    Oct 1, 2017, 00:00

  • Impact of Global Budget on Personal Medical Expense for Inpatient with Respiratory Disease- An Interrupted Time Series Analysis

    Oct 1, 2017, 00:00

  • Cost Efficiency Analysis of A New Arrhythmia Detection Algorithm In A Miniaturized Insertable Cardiac Monitor

    Oct 1, 2017, 00:00

  • How to Maintain Pharmaceutical Access in Crisis- The Iran FDA Experience

    Oct 1, 2017, 00:00

  • Qualitative Exploration of the Real-World Experiences of Men Receiving or Refusing Chemotherapy (Docetaxel) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (MHSPC)

    Oct 1, 2017, 00:00

  • How Beneficial Is Individual Patient Data In A Mixed Treatment Comparison?

    Oct 1, 2017, 00:00

  • Shouldn’t Nice Cost-Effectiveness Thresholds Be Changing With The Times?

    Oct 1, 2017, 00:00

  • Quimioterápicos Orais No Tratamento De Segunda Linha Do Carcinoma De Células Renais- Comparação De Custos E Perfil De Reações Adversas

    Oct 1, 2017, 00:00

  • Concept of Pharmaceutical Care In The Brazilian Legislation

    Oct 1, 2017, 00:00

  • Treatment Strategies and Outcomes In Patients Treated For Relapsed Refractory Multiple Myeloma Over 3 Years- Premiere Study

    Oct 1, 2017, 00:00

  • How Can Middle-Income Countries Get A Valid Estimate Of Cost-Effectiveness Of A Drug More Efficiently And Effectively?

    Oct 1, 2017, 00:00

  • Increased Prevalence of Diabetes In The Netherlands Is Only Partly Explained By Changes In Age And Sex Over Time

    Oct 1, 2017, 00:00

  • Cost –Effectiveness of Obinutuzumab As Frontline Treatment For Unfit Patients With Chronic Lymphocytic Leukemia In Republic of Macedonia

    Oct 1, 2017, 00:00

  • How Ireland's Colorectal Screening Programme Could Save More Lives, Save Money and Stay Within Existing Colonoscopy Capacity Limits- Evidence from the Miscan Microsimulation Model

    Oct 1, 2017, 00:00

  • Economic Analysis of Hepato Cellular Carcinoma Treatment by Severity of Disease

    Oct 1, 2017, 00:00

  • Comparison of Icd-9 to Icd-10 Crosswalks Derived By Physician and Clinical Coder Vs. Automated Methods

    Oct 1, 2017, 00:00

  • Burden Of Endometriosis And Related Symptoms In A Nationwide Health Plan With 2 Million Members

    Oct 1, 2017, 00:00

  • Well Thought Through But Badly Carried Out- An Evaluation Of The Reporting Quality Of Statutory Health Insurance Claims Data Analyses To Quantify The Target Population In Early Benefit Assessment In Germany

    Oct 1, 2017, 00:00

  • Budget Impact of Alteplase In Treatment of Acute Ischemic Stroke In Turkey

    Oct 1, 2017, 00:00

  • Resource Use and Associated Costs of Managing Docetaxel-Related Neutropenic Sepsis in Patients with Advanced Non-Small Cell Lung Cancer in The UK Nhs- Reveal-Ns

    Oct 1, 2017, 00:00

  • The First Five Months Of National Prescription Monitoring In Finland

    Oct 1, 2017, 00:00

  • The Economic Evaluation Of Continuous Ambulatory Peritoneal Dialysis (CAPD) and Hemodialysis In Indonesia

    Oct 1, 2017, 00:00

  • Dry-Weight Assessment Among Hemodialysis Patients Using Body Composition Monitor

    Oct 1, 2017, 00:00

  • Sun Protection Knowledge And Behaviour Among University Students In Hungary

    Oct 1, 2017, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Ankylosing Spondylitis at 52 Weeks from the Irish Payer Perspective

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Physicians' Guideline Adherence for Osteoporosis In Germany

    Oct 1, 2017, 00:00

  • Assessment of Public Opinion Regarding The Ethics of Nice CDF, HST, and End-of-Life Criteria for Drug Reimbursement

    Oct 1, 2017, 00:00

  • Socioeconomic And Environmental Determinants In Breast Cancer Incidence And Mortality- Scientiometric Review, 2006 - 2016

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Tigecycline In Comparision With Imipenem/Cilastatin Or Piperacillin/Tazobactam In The Treatment Of Complicated Intra-Abdominal Infections- A Perspective Of Iranian Health Systems

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Sequential Vaccination Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) And 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) On Adult Population In South Korea

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis Comparing the Originator Recombinant Human Alfa to their Biosimilars Follitropin Alfa for the Treatment of Infertility

    Oct 1, 2017, 00:00

  • Breast Cancer Diagnosis Process- An Integrative Evaluation of Five Components

    Oct 1, 2017, 00:00

  • The Effect of Smoking Cessation Interventions in Patients with Copd- A Systematic Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Switching To Insulin Degludec (IDEG) In Real-World Clinical Practice In Italy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of The Paliperidone Palmitate 3-Month Formulation Versus 1-Month Formulation From A Healthcare Payer Perspective

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Peritoneal Dialysis Provision for the Treatment of Chronic Kidney Disease from Public Health Perspective in Chile

    Oct 1, 2017, 00:00

  • Comparative Study Of Healthcare Resource Utilization (HRU) Outcomes Between Chronic Lymphocytic Leukemia (CLL) Patients Treated With Ibrutinib Versus Non-Ibrutinib Treated Patients

    Oct 1, 2017, 00:00

  • Comparison Of Utility Cost In Three Commercially Available Precision Medicine Approaches In Oncology

    Oct 1, 2017, 00:00

  • Electronic Capture of Clinical Outcome Assessment Data- Why is it Not Used More in Clinical Studies?

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life after Oncological Resection and Reconstruction of the Chest Wall

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis Of Dalbavancin Use In Acute Bacterial Skin And Soft Tissue Infections

    Oct 1, 2017, 00:00

  • Population Health Status Based On The EQ-5D-3L-Y Among Adolescents In Sweden - Results By Sex, Age And Socio-Economic Status

    Oct 1, 2017, 00:00

  • Relationship Between The Price Differences In Orphan Drugs With More Than One Benefit Assessment In Amnog And The Potential Influencing Factors

    Oct 1, 2017, 00:00

  • Treatment Choices Based On Multiplatform Profiling Platform, Unlike Those With Sequencing Alone, Do Not Cause A Cost Explosion In Refractory Cancer Patients

    Oct 1, 2017, 00:00

  • Secukinumab Vs. Adalimumab for Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis at 52 Weeks from an Argentinian Perspective

    Oct 1, 2017, 00:00

  • Patient Preferences Regarding Treatment Options for Relapsed Refractory Multiple Myeloma (RRMM)

    Oct 1, 2017, 00:00

  • Trends In Fda Drug Promotion Enforcement Letters Over A Ten-Year Period

    Oct 1, 2017, 00:00

  • Dose Appropriateness of Antibiotics- Deciphering Infections in Renal Imprirement

    Oct 1, 2017, 00:00

  • The Economic Burden of Varicella in Peru

    Oct 1, 2017, 00:00

  • Cost Drivers of Lung Cancer Care- Results From A Retrospective Chart Review of Pretreated Advanced Nsclc Patients in Europe

    Oct 1, 2017, 00:00

  • The Economic Impact of Caregiver For Patients With Atrial Fibrillation- An Italian Survey

    Oct 1, 2017, 00:00

  • Evaluation of The "Sophia Asthme" Support Programme for Asthmatic Adult Patients

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Comparing Blinatumomab In The Treatment Of Adults With Philadelphia Chromosome-Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (All) With Flag-Ida And Hyper CVAD

    Oct 1, 2017, 00:00

  • The Design of Economic Evaluation and Budget Impact Analysis Of Biosimilars- A Qualitative Study

    Oct 1, 2017, 00:00

  • Leadership In Nursing

    Oct 1, 2017, 00:00

  • Quick and Comprehensive Assessment of Narrow Band Imaging (NBI) Using in Digestive Tract Examination

    Oct 1, 2017, 00:00

  • Drug Utilization Study Of Antibacterial In The Medical Intensive Care Unit (Micu) Of A Chitwan Medical College Teaching Hospital(Cmcth), Bharatpur, Chitwan, Nepal

    Oct 1, 2017, 00:00

  • The Economic Burden Of Acute Bacterial Rhinosinusitis And Acute Otitis Media In Turkey- An Epidemiology Based Cost Of Illness Study With Respect To Clinical Practice And Available Guidelines

    Oct 1, 2017, 00:00

  • Pharmacology for Peripheral Arterial Disease in the Netherlands; Patient Journey and Platelet Aggregation Inhibitor Prescription

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of The Use of Enstilar® Compared To Dovobet® Gel In The Treatment of Psoriasis In Italy

    Oct 1, 2017, 00:00

  • The Role Of General Practitioners In Diagnostic Delay In Case Of Cutaneous Malignant Melanoma Patients

    Oct 1, 2017, 00:00

  • Bevacizumab for Breast Cancer- Scientific Evidence Versus Real World Data (RWD) in Brazil

    Oct 1, 2017, 00:00

  • Using Outcome Data to Inform Healthcare Professional – Patient Discussion- A Database of Treatment Effects

    Oct 1, 2017, 00:00

  • Cost Minimization Analysis of The Selective Aromatase Inhibitors; Anastrozole, Versus Letrozole and Exemestane for The Management of Breast Cancer From Patient Perspective in Egypt

    Oct 1, 2017, 00:00

  • Effect of Anti-Diabetic Drugs On Risk of Fracture In Type 2 Diabetes Mellitus Patients- A Network Meta-Analytic Synthesis of Randomized Controlled Trials of Thiazolidinediones

    Oct 1, 2017, 00:00

  • Prognostic and Treatment Effect Modifying Baseline Factors for Visual Functioning Response in Non-Infectious Uveitis of the Posterior Segment Treated with Intravitreal Sirolimus

    Oct 1, 2017, 00:00

  • Enhanced Surgical Recovery Program Perioperative Goal Directed Therapy (PGDT) Economic Benefit

    Oct 1, 2017, 00:00

  • Patient Outcomes In Wales- The Proms, Prems Effectiveness Programme (PPEP)

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Abobotulinumtoxin A For Hemiparesis In Adults With Upper Limb Spasticity After Stroke or Traumatic Brain Injury In The United Kingdom – A Bayesian Analysis

    Oct 1, 2017, 00:00

  • Will 2017 Updates To The Highly Specialised Technologies Programme Benefit or Harm Vulnerable Patients?

    Oct 1, 2017, 00:00

  • Societal Preferences For Funding Orphan Drugs In The UK- An Application Of Value Based Pricing Using Discrete Choice Experiment Methods

    Oct 1, 2017, 00:00

  • Healthcare Resource Use (HRU) in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1)- Retrospective Analysis of The Kids’ Inpatient Database (KID)

    Oct 1, 2017, 00:00

  • Damned if You ‘D’? Evidence the Selection of the Appraisal Committee May Affect Nice Technology Assessmet Outcomes

    Oct 1, 2017, 00:00

  • Validação Do Método Simple Exponential Smoothing with Additive Para Realização De Previsões De Gasto Com Importação De Produtos Farmacêuticos

    Oct 1, 2017, 00:00

  • Radar – An Important Tool for Horizon Scanning Dissemination in Brazil

    Oct 1, 2017, 00:00

  • Evaluating Community Pharmacists’ Response To Adverse Drug Events Among Women With Pcos- A Simulated-Client Study

    Oct 1, 2017, 00:00

  • Assessing The Joint Probability Of Cost-Effectiveness And Affordability In Decision Making

    Oct 1, 2017, 00:00

  • Evaluación De Pertinencia Científica Y Análisis De Costo-Efectividad En Las Intervenciones De Salud

    Oct 1, 2017, 00:00

  • real-World Data (RWD) On The Attainment Of Composite Quality Measures (Cqm) In A Brazilian Population With Self-Reported Type-2 Diabetes Mellitus (T2DM)

    Oct 1, 2017, 00:00

  • Boosting Home Dialysis Uptake By Setting Fixed Modality Ceilings- Is It An Evidence-Based Policy Approach?

    Oct 1, 2017, 00:00

  • Probabilistic Cost-Utility Analysis of Pergoveris in Women Patients Undergoing IVF

    Oct 1, 2017, 00:00

  • Public Hospital Supply Chain- Current View And Critical Issues In Italy

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Ustekinumab in Moderate to Severely Active Crohn’s Disease in Sweden

    Oct 1, 2017, 00:00

  • A Cost Minimization Analysis of Azelastine/Fluticasone Combination Nasal Spray Versus Azelastine And Fluticasone Nasal Sprays Monotherapy In Moderate To Severe Allergic Rhinitis- An Experience From Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • Acute Lymphoblastic Leukaemia’s Burden Of Disease In Portugal

    Oct 1, 2017, 00:00

  • Impact Of Lifestyle Education And Pharmacist Intervention Of Drug-Related Problems On Elders At High Risk Of Having Dementia

    Oct 1, 2017, 00:00

  • A Pilot Study About The Appropriateness Of The Breast Cancer Care Pathway In A Local Health Authority ASL CN2 (Piedmont, ALBA BRA-Italy) based on E.Pic.A. (Economic Appropriateness Of An Integrated Care Pathway) Protocol

    Oct 1, 2017, 00:00

  • The Early Bird Catches The Worm- Measuring The Potential Value Of Mesenchymal Stem Cells Therapy For Septic Shock Using The Early Health Economic Evaluation

    Oct 1, 2017, 00:00

  • Incidence Of Surgery For Inflammatory Bowel Disease Within 12 Months Of Initiation Of Vedolizumab Or Infliximab

    Oct 1, 2017, 00:00

  • Evaluation Of Measles Vaccination Coverage In Austria

    Oct 1, 2017, 00:00

  • Health Economic Cost Study For Senior Citizens In Ecuador

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of First-Line Ceritinib in The Treatment of Alk+ Metastatic Non-Small Cell Lung Cancer (NSCLC) in The United States

    Oct 1, 2017, 00:00

  • Differences in Distributional Properties and Responsiveness Between A Generic (EQ-5d) and Disease-Specific (ASUI) Utility Instrument in Patients with Severe Eosinophilic Asthma

    Oct 1, 2017, 00:00

  • Cost Impact of Protocol Compliance for Cancer Treatment Plans in The Private Healthcare Environment

    Oct 1, 2017, 00:00

  • Public Funding Of Cancer Treatment- Changes To The Process And Success Rate Over Time In Australia

    Oct 1, 2017, 00:00

  • Quantitative Assessment of Ophthalmologist Prescribing Patterns for Severe Vernal Keratoconjunctivitis (VKC) To Inform Payer Decision Making In The Eu

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece

    Oct 1, 2017, 00:00

  • Evaluating Cost of Regimens in Hepatitis C Treatment from Healthcare Payer Vietnam’s Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Eicosapentaenoic Acid (EPA) On Primary Prevention of Cardiovascular Disease

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of The Use Of Daclatasvir + Asunaprevir in The Treatment of Patients with Chronic Hepatitis C in Peru

    Oct 1, 2017, 00:00

  • Instructions for Authors

    Oct 1, 2017, 00:00

  • The Impact Of Long Acting Injectable Antipsychotics On The Health And Economic Outcomes Of Schizophrenia Patients In Brazil

    Oct 1, 2017, 00:00

  • A Preliminary Cost Analysis of Schizophrenic Patients Stabilized on 1-Monthly Long Acting Paliperidone Palmitate (PP1M) Injection Switching To Paliperidone Palmitate 3-Monthly Formulation (PP3M) In The Public Sector of Hong Kong

    Oct 1, 2017, 00:00

  • Health Care Resource Utilization Among Patients With Moderate-To-Severe Plaque Psoriasis In Brazil

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization in Patients with Moderate to Severe Ulcerative Colitis- A Brazilian Real World Study

    Oct 1, 2017, 00:00

  • Comparing Efficacy of Guselkumab Versus Ustekinumab in Moderate to Severe Psoriasis Patients - An Adjusted Comparison Based on Voyage 12 and Navigate Trials

    Oct 1, 2017, 00:00

  • HTA Reports In Gene And Cell Therapy Products- A Scoping Review

    Oct 1, 2017, 00:00

  • Yellow Fever’s Next Move- The Rising Fear

    Oct 1, 2017, 00:00

  • Utility Meta-Regression; Frequentist Vs Bayesian Approaches in Multiple Myeloma

    Oct 1, 2017, 00:00

  • Development of a New Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis- Nash-Check

    Oct 1, 2017, 00:00

  • Length of Hospitalisation After Attune® Knee Joint Arthroplasty (TKA) - Results of A German Retrospective Database Analysis

    Oct 1, 2017, 00:00

  • The Success Of EU Omp Legislation- An Empirical Analysis

    Oct 1, 2017, 00:00

  • Fatores Associados Aos Gastos com Imagenologia No Sistema Unico De Saude Brasileiro

    Oct 1, 2017, 00:00

  • Multiple Myeloma- Epidemiology and Burden of Disease Analysis in Latin America

    Oct 1, 2017, 00:00

  • Contrasting Improving Rates of Cancer Survival In The Context of Life Years Lost Compared To The General Population

    Oct 1, 2017, 00:00

  • Survival Outcomes Predicted By A Discrete Event Simulation Model For Renal Cell Carcinoma For Use In A Cost Effectiveness Analysis- A Comparison With A Traditional Partitioned Survival Model

    Oct 1, 2017, 00:00

  • Are Generic Health State Utility Instruments Sufficiently Sensitive To Capture Changes In Health-Related Quality of Life In Patients With Visual Disorders?

    Oct 1, 2017, 00:00

  • Identifying Inpatients To Outpatient Parenteral Antimicrobial Therapy- A Point Prevalence Study

    Oct 1, 2017, 00:00

  • Modelling The Effectiveness of Ibrutinib Versus Physician’s Choice (PC) In Relapsed or Refractory (RR) Waldenström’s Macroglobulinemia (WM) Within England

    Oct 1, 2017, 00:00

  • Persistence in Hypertension Therapy in Patients with and Without Depression in Germany

    Oct 1, 2017, 00:00

  • Medication Use During Pregnancy in the Netherlands- A Population-Based Study

    Oct 1, 2017, 00:00

  • Challenges and Future Perspectives on The Reimbursement of Advanced Therapy Medicinal Products

    Oct 1, 2017, 00:00

  • Cost Illness Of Rsv Infection In Colombia

    Oct 1, 2017, 00:00

  • Estimating the Comparative Accuracy of Diagnostic Tests- AN Example using Typhoid Fever

    Oct 1, 2017, 00:00

  • Comparison of Health Technology Assessments in Rheumatology from 2012 To 2016

    Oct 1, 2017, 00:00

  • Health Insurance Cost Of Migraine In Hungary- A Cost Of Illness Study

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Supra-Ciliary Microstent Device Utilization In Primary open Angle Glaucoma Patients In A Spanish Hospital Outpatient Setting

    Oct 1, 2017, 00:00

  • Mapping From The Womac To The EQ-5D-5L Questionnaire- Comparison Of Different Methodologies

    Oct 1, 2017, 00:00

  • Caracterización Clínica Y Económica De Hospitalización Por Varicela En Niños En La Región Metropolitana Y Región De Valparaíso, Chile

    Oct 1, 2017, 00:00

  • The Prevalence of Patients At Very High Risk For Cardiovascular Events In The United Kingdom

    Oct 1, 2017, 00:00

  • Efficacy Of Antioxidant Supplements On Prevention And Amelioration Of Diabetes-Induced Nephropathy- A Systematic Review And Meta-Analysis Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Assessing the Longer-Term Efficacy of Biologic Therapies and Apremilast for Patients with Moderate-To-Severe Psoriasis- A Systematic Review and Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Cost Saving Due To Self-Care Behavior Of Cardiovascular Patients

    Oct 1, 2017, 00:00

  • Limitaciones De Las Evaluaciones Económicas En Salud En La Asignación De Recursos Para Medicamentos Para Enfermedades Raras- Un Scoping Review

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact At Health Care Perception At Patients Diagnosed With Persistent Severe Asthma

    Oct 1, 2017, 00:00

  • Transparency Matters- Use Of Digital Software Platform In Replicating Systematic Reviews

    Oct 1, 2017, 00:00

  • The Economic And Humanistic Burden of Patients on Treatment for Neovascular Age-Related Macular Degeneration

    Oct 1, 2017, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78 (current)
  • 79
  • 80
  • »